Literature DB >> 30844469

Evaluation of myocardial fibrosis in diabetes with cardiac magnetic resonance T1-mapping: Correlation with the high-level hemoglobin A1c.

Yue Gao1, Zhi-Gang Yang2, Yan Ren3, Xi Liu2, Li Jiang2, Lin-Jun Xie4, Bi-Yue Hu2, Meng-Ting Shen2, Hua-Yan Xu4, Zhen-Lin Li2, Chun-Chao Xia2, Yu-Ming Li2, Li-Ling Deng3, Ming-Yan Deng3, Xiao-Yue Zhou5, Ying-Kun Guo6.   

Abstract

AIM: The aim of the study was to assess the extracellular volume fraction (ECV) in type 2 diabetes mellitus (T2DM) patients with different level of hemoglobin A1c (HbA1c) by cardiac magnetic resonance (CMR), and the ability of HbA1c to predict myocardial fibrosis.
METHODS: In total, 80 T2DM patients and 20 age- and sex-matched controls were prospective enrolled and underwent CMR to obtain ECV value and LV function parameters. We divided all patients into a group of HbA1c < 7.0% and a group of HbA1c ≥ 7.0%.
RESULTS: In the higher HbA1c group the ECV value (all p < 0.001) was higher than both lower HbA1c group (36.23% vs. 32.19%, p < 0.001) and controls (36.23% vs. 29.73%, p < 0.001). HbA1c was positively associated (β = 0.36, p = 0.004) with ECV, and it was also an independent predictor of myocardial fibrosis (OR = 2.00, P = 0.014). The ROC analysis showed that 7.1% was the optimal cutoff value of HbA1c that predicted the risk of myocardial fibrosis with high diagnostic accuracy (area under the curve = 0.78).
CONCLUSION: T1 mapping provided myocardial fibrosis information in T2DM patients. HbA1c is positively correlated with myocardial fibrosis and can be an independently predictor of myocardial fibrosis, which may be helpful for the clinical decision-making of blood glucose control.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac magnetic resonance; Diabetic cardiomyopathy; Hyperglycemia; Myocardial fibrosis; T1 mapping

Mesh:

Substances:

Year:  2019        PMID: 30844469     DOI: 10.1016/j.diabres.2019.03.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

Review 1.  Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.

Authors:  Benedict J Maliakkal
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 2.  Diabetic fibrosis.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-12-28       Impact factor: 5.187

3.  Serial coronary computed tomography angiography-verified coronary plaque progression: comparison of stented patients with or without diabetes.

Authors:  Rui Shi; Ke Shi; Zhi-Gang Yang; Ying-Kun Guo; Kai-Yue Diao; Yue Gao; Yi Zhang; Shan Huang
Journal:  Cardiovasc Diabetol       Date:  2019-09-24       Impact factor: 9.951

4.  Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a 1H-magnetic resonance spectroscopy study.

Authors:  Yue Gao; Yan Ren; Ying-Kun Guo; Xi Liu; Lin-Jun Xie; Li Jiang; Meng-Ting Shen; Ming-Yan Deng; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2020-05-29       Impact factor: 9.951

5.  Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure.

Authors:  Shaomin Yang; Haixiong Chen; Kuan Tan; Fusheng Cai; Yongxing Du; Weibiao Lv; Qiugen Hu; Yunzhao Hu; Yuli Huang
Journal:  Oxid Med Cell Longev       Date:  2020-05-06       Impact factor: 6.543

6.  Association of myocardial fibrosis detected by late gadolinium-enhanced MRI with clinical outcomes in patients with diabetes: a systematic review and meta-analysis.

Authors:  Zhi-Gang Yang; Ying-Kun Guo; Zhi Yang; Rong Xu; Jia-Rong Wang; Hua-Yan Xu; Hang Fu; Ling-Jun Xie; Meng-Xi Yang; Lu Zhang; Ling-Yi Wen; Hui Liu; Hong Li
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

7.  T1 values and extracellular volume fraction in asymptomatic subjects: variations in left ventricular segments and correlation with cardiovascular risk factors.

Authors:  Moon Young Kim; Soo Jin Cho; Hae Jin Kim; Sung Mok Kim; Sang-Chol Lee; MunYoung Paek; Yeon Hyeon Choe
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996

Review 8.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

9.  Azathioprine pretreatment ameliorates myocardial ischaemia reperfusion injury in diabetic rats by reducing oxidative stress, apoptosis, and inflammation.

Authors:  Cuijie Lu; Ling Liu; Shuai Chen; Junfei Niu; Sheng Li; Wenxian Xie; Xiang Cheng
Journal:  Clin Exp Pharmacol Physiol       Date:  2021-08-22       Impact factor: 2.963

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.